Pharma and Biotech Daily: Legal Battles, Acquisitions, Policy Changes, and Innovation Podcast Por  arte de portada

Pharma and Biotech Daily: Legal Battles, Acquisitions, Policy Changes, and Innovation

Pharma and Biotech Daily: Legal Battles, Acquisitions, Policy Changes, and Innovation

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medical societies, including the American Academy of Pediatrics, have filed a lawsuit against RFK Jr. over changes to COVID-19 vaccine policies. They argue that his directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and children puts them at risk of serious illness. Concentra has acquired struggling biotech company Cargo Therapeutics in a $200 million buyout. President Trump's tax law has restored orphan drug exemptions, cut Medicaid funding, and threatened the 340B program, while giving pharmacy benefit managers a pass. The ALS community has petitioned the FDA to reconsider Brainstorm's cell therapy Nurown, citing recent survival data. Drug developers are exploring new digitization strategies to optimize processes and embrace technology in drug development. Overall, the text discusses legal action against RFK Jr. over vaccine policy changes, recent acquisitions in the biotech industry, implications of Trump's tax law on healthcare programs, petitions regarding ALS therapies, digitization strategies in drug development.
Todavía no hay opiniones